Get the full picture
Sign in to uncover key details.
Ratio Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Design Center Pl Ste 19-601, Boston, M...Phone Number
(617) 371-8898Website
www.ratiotx.comRevenue
$13.5 MillionIndustry
About Ratio Therapeutics
Ratio Therapeutics is a biopharmaceutical company focused on developing targeted radiopharmaceuticals for the treatment of cancer. Its platform combines proprietary targeting scaffolds, pharmacokinetic modulation, and advanced chelation technologies to create small-molecule agents designed to selectively target cancer cells while carrying either imaging or therapeutic radioisotopes. The company uses a theranostic approach, pairing diagnostic imaging with targeted radiotherapy to support the identification and development of promising drug candidates. Its work brings together expertise across drug discovery, engineering, clinical research, and radiopharmaceutical development, with the goal of advancing more precise and effective cancer treatments.Explore more
Ratio Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Ratio Therapeutics
Compare insights from companies similar to Ratio Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ratio Therapeutics Tech Stack
A closer look at the technologies used by Ratio Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ratio Therapeutics
Sign Up For FreeTo access detailed company insights
Ratio Therapeutics is a biopharmaceutical company focused on developing targeted radiopharmaceuticals for the treatment of cancer. Its platform combines proprietary targeting scaffolds, pharmacokinetic modulation, and advanced chelation technologies to create small-molecule agents designed to selectively target cancer cells while carrying either im... Read More
